Skip to main content
OpenTrials
Completed

NCT Number: NCT01118000

Study on the Cardioprotection and Humoral Mechanism of Limb Ischemia Preconditioning

Numerous studies Have shown that limb ischemic preconditioning can protect vital organs (including the heart) from ischemia-reperfusion injury,which has a broad application prospect.But its mechanism is still unclear. Evidence showed that humoral mechanisms may play an important role. This study was carried out on the limb ischemic preconditioning in healthy volunteers, collected their serum at different time points before and after treatment,classified and identified the serum proteins during different periods of limb ischemic preconditioning,by using methods including high abundant protein removal,Two-dimensional electrophoresis chromatography and mass spectrometry,then analysed activation and synthesis of the proteins in order to search for the proteins or peptides whose synthesis was activated by ischemic preconditioning. This study will be the first systemic explore of the changes in serum proteins of limb ischemic preconditioning in human body,and lay theoretical basis for the clinical application of limb ischemic preconditioning and for further explore of its humoral mechanism,thus provide clues for searching for protein or peptide having protective effects for organs.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

proteomics lab of Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

About this study

We aim to assess whether limb ischemic preconditioning protects remote tissue or organs through a humoral mechanism.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy volunteers aging 20-30 years old
  • no cardiac,hepatic or renal,peripheral vascular diseases
  • be willing to enter our study and sign an written informed consent

Exclusion criteria

  • younger than 20 years old or older than 30 years old
  • having cardiac,hepatic or renal,peripheral vascular diseases
  • refuse to enter our study or sign an written informed consent

Treatment and study plan

limb ischemia preconditioning

Procedure

limb ischemic preconditioning consists of three 5-min cycles of left upper limb ischemia induced by a blood pressure cuff placed on the left upper arm and inflated to 200 mmHg,with an intervention 5-min of reperfusion during which the cuff was deflated.

Other names: remote ischemia preconditioning

Primary outcomes

  1. Transient limb ischemia would change expression of several serum proteins in humans,indicating a humoral mechanism for its organ protection.

    Time frame: two years

    Proteomics analysis of the serum proteins.

Secondary outcomes

  1. A questionnaire study of the acceptability of transient limb ischemia in healthy conscious subjects.

    Time frame: one year

    Transient limb ischemia as a remote ischemic preconditioning stimulus has been shown an effective and non-invasive strategy to protect remote tissue or organs from an extended ischemic event. But the acceptability of human subjects remains unknown. Our study aims to assess the acceptability of this transient limb ischemia protocol in healthy conscious subjects.

Sponsors and collaborators

Lead sponsor

Sun Yat-sen University

Other

Registry information

Important dates

Study start
2009
Primary completion
2009
Study completion
2010
First posted
May 6, 2010
Registry last updated
Jul 28, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.